Logo
Sunekos Body

Sunekos Body

Sunekos

Aesthetic / Body‑contouring Injectable
  • Class III CE‑marked medical device. :contentReference[oaicite:33]{index=33}
Dermal biostimulator / body mesotherapy gel (HA + amino acids)

Description

Sunekos Body is an injectable body‑mesotherapy gel combining low‑density hyaluronic acid (HA) with a patented amino‑acid complex (HY6AA). It is formulated to treat skin laxity and stretch marks on larger body areas (arms, inner thighs, abdomen, knees, etc.) by stimulating extracellular matrix (ECM) regeneration — promoting collagen type IV, elastin and skin structural protein synthesis, thereby improving skin firmness, elasticity, volume, and reducing stretch marks and skin laxity. :contentReference[oaicite:2]{index=2}

Bnefits

  • Stimulates ECM regeneration — collagen type IV, elastin and other structural proteins production for firmer, stronger skin. :contentReference[oaicite:3]{index=3}
  • Improves skin elasticity and firmness on body areas. :contentReference[oaicite:4]{index=4}
  • Reduces appearance of stretch marks (striae distensae) and improves skin texture. :contentReference[oaicite:5]{index=5}
  • Provides volume restoration and smoothing for body contour — helpful for sagging or crepey skin. :contentReference[oaicite:6]{index=6}
  • Enhances skin hydration and dermal structure stability by supplying hyaluronic acid. :contentReference[oaicite:7]{index=7}

Indications

  • Skin laxity on body (arms, inner thighs, abdomen, knees, etc.) :contentReference[oaicite:8]{index=8}
  • Stretch marks / striae distensae (early and mature) on body skin. :contentReference[oaicite:9]{index=9}
  • Sagging or crepey skin after weight loss or pregnancy, or age‑related dermal thinning. :contentReference[oaicite:10]{index=10}
  • Body contour improvement where volume loss or depressed skin areas exist. :contentReference[oaicite:11]{index=11}

Composition

  • Low‑density hyaluronic acid (HA) – sodium hyaluronate, volume: 10 ml vial. :contentReference[oaicite:12]{index=12}
  • Amino‑acid complex (HY6AA): Glycine, L‑Proline, L‑Lysine, L‑Leucine, L‑Valine, L‑Alanine, 300 mg vial. :contentReference[oaicite:13]{index=13}

Formulation

  • Two‑component injectable system: one vial of HA solution (10 ml), one vial of amino‑acid powder (300 mg) to be reconstituted prior to injection. :contentReference[oaicite:14]{index=14}
  • Prepared for intradermal/subdermal injection by trained medical professionals under sterile conditions. :contentReference[oaicite:15]{index=15}

Packaging

  • Box containing 1 vial of 10 ml HA solution + 1 vial of 300 mg amino‑acid powder. :contentReference[oaicite:16]{index=16}

Usage

  • To be administered only by licensed medical practitioners or trained aesthetic professionals. :contentReference[oaicite:17]{index=17}
  • Reconstitute amino‑acid vial with HA vial under aseptic conditions immediately before injection. :contentReference[oaicite:18]{index=18}
  • Inject using a fine needle or cannula into the dermal layer (needle or cannula technique) depending on the area. :contentReference[oaicite:19]{index=19}
  • Typical treatment includes 3–4 sessions spaced 15–21 days apart; volume per session depends on treated area (e.g., 5–10 ml per session depending on size of area). :contentReference[oaicite:20]{index=20}

Contraindications

  • Hypersensitivity / allergy to hyaluronic acid or amino acids. :contentReference[oaicite:23]{index=23}
  • Active skin inflammation, infection, or compromised dermal integrity at injection site. :contentReference[oaicite:24]{index=24}
  • Pregnancy and breastfeeding (not recommended) as per some product advisories. :contentReference[oaicite:25]{index=25}
  • Any autoimmune or collagen‑vascular disorders, or bleeding/clotting disorders (per product contraindications listed). :contentReference[oaicite:26]{index=26}

Adverse Effects

  • Transient redness, swelling, bruising or tenderness at injection site. :contentReference[oaicite:27]{index=27}
  • Possible localized nodules or lumps if improperly administered. :contentReference[oaicite:28]{index=28}
  • Risk of hypersensitivity or allergic reaction in sensitive individuals. :contentReference[oaicite:29]{index=29}

Storage Conditions

  • Store at 15–25 °C in original sterile packaging. :contentReference[oaicite:30]{index=30}
  • Protect from frost, heat, and direct sunlight. :contentReference[oaicite:31]{index=31}
  • Use immediately after reconstitution; do not reuse or re‑sterilize. :contentReference[oaicite:32]{index=32}

Duration

Initial course: 3\u20134 sessions over ~1.5\u20132 months; maintenance recommended every 6\u201312 months depending on skin condition. :contentReference[oaicite:21]{index=21}

Onset

Improvements often become visible over weeks (skin texture, elasticity, stretch\u2011mark appearance) with optimal results in 2\u20134 months. :contentReference[oaicite:22]{index=22}

Browse more Aesthetic / Body\u2011contouring Injectable

Top Treatments

Top Cities in the UK